Clinical-stage biopharmaceutical company developing psychedelic-inspired medicines.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Mind Medicine (MindMed) Inc..
The 1 sources with the most insights about Mind Medicine (MindMed) Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Highly bullish following 'very convincing' Phase 3 results for an LSD-like product; upcoming psilocybin results in August are a major catalyst.
Highly bullish following 'very convincing' Phase 3 results for an LSD-like product; upcoming psilocybin results in August are a major catalyst.
Other assets that creators frequently mention in the same content as Mind Medicine (MindMed) Inc..
The most active sources covering Mind Medicine (MindMed) Inc. (MNMD) on Kazuha are @realvisionfinance. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Mind Medicine (MindMed) Inc. (MNMD) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Mind Medicine (MindMed) Inc. (MNMD) most frequently also discuss MU, GBP, BTC, MSTR, ENVB. See the "Discussed alongside" section above for full asset pages.